← Back to blog

Statins and Testosterone: What the Evidence Shows

November 15, 2026
Statins and Testosterone: What the Evidence Shows

Do statins lower testosterone? In some studies, total testosterone is slightly lower in men taking a statin. The best randomized evidence shows a small average shift, and average levels do not fall below the normal range. Whether that shift means anything for how you feel is a separate question, and one that Swedish clinical guidance answers with symptoms and repeated morning blood tests, not with a single number. If you take a statin and care about long-term performance, the disciplined move is to understand the size of the effect, keep your cardiovascular plan intact and bring a precise question to your physician.

Viridos
viridos.co
Support Consistent Performance Over Time
VIRIDOS is a premium Swedish men’s performance brand for disciplined professionals focused on vitality, resilience and long-term performance.
Visit

TL;DR

  • A 2024 meta-analysis found statin use associated with a small average drop in total testosterone, and levels did not fall below normal on average.
  • Cochrane's review of atorvastatin trials found no statistically significant difference from placebo, with low-certainty evidence.
  • Free testosterone, LH, estradiol and SHBG showed no significant differences in the 2024 review, and clinical symptoms could not be assessed.
  • Swedish guidance defines low testosterone by symptoms plus repeated low fasting morning results. Do not stop or change a statin without your physician.
  • If you suspect a hormonal issue, test correctly: fasting, early morning, and repeated if low.

Table of Contents

Why men over 40 ask this question

By your forties and fifties, two things tend to arrive together: a statin prescription, and the sense that drive, recovery or libido are not what they were. It is natural to connect them. Statins work on the pathway the body uses to make cholesterol, and cholesterol is the raw material for steroid hormones, testosterone included. That biological logic is why the question has been studied for more than two decades.

Logic is not evidence, though. The useful question is how large any effect is, how certain the data are, and whether the effect is clinically relevant for a man in a demanding role. The sections below take those in order.

What the largest reviews found

The 2024 systematic review and meta-analysis

The most recent large synthesis, by Glina and colleagues, pooled studies through May 2023. It found that statin use was associated with a lower total testosterone, but the size depended on study design. In five randomized trials the mean reduction was 13.12 ng/dL (95% confidence interval 1.16 to 25.08). Across 15 prospective studies it was 9.11 ng/dL, and in six cross-sectional studies it was 55.02 ng/dL.

Testosterone reductions by study design

The cross-sectional number is the largest, and it is also the least reliable. Those studies compare different men at one moment, so differences in weight, age and metabolic health can drive the gap, and the results varied widely between studies (I² of 91%). The randomized trials were highly consistent (I² of 0%) and show the smaller figure.

Two further points from the same review matter more than the headline. The decrease did not, on average, bring levels below normal. And the authors found no significant differences in free testosterone, LH, estradiol or SHBG. They also stated that clinical symptoms could not be assessed, and that the included studies varied in statin type, dose, exposure time and design.

Cochrane on atorvastatin

Cochrane's review of six randomized trials of atorvastatin, searching through November 2020, found no statistically significant difference in total testosterone against placebo in men: a mean difference of −0.20 nmol/L (95% CI −0.77 to 0.37). The reviewers rated the certainty as low to very low and called for more trials.

An earlier randomized-trial analysis

In 2013, Schooling and colleagues pooled randomized trials covering 501 men. They reported a mean reduction of 0.66 nmol/L, roughly 3.4%. They also noted that the clinical significance is hard to gauge, because the normal range for testosterone is wide and sexual function does not map neatly onto one concentration.

How to read these together

The reviews are not contradictory. One finds a small statistically detectable reduction, one finds no significant difference, and they use different units (ng/dL and nmol/L) and different trial sets. Read side by side, they say the same thing: any average effect is small, the evidence is not high-certainty, and nothing shows that the average man on a statin drops into a low range.

SourceDesignFinding on total testosterone
Glina et al., 20245 randomized trialsMean reduction 13.12 ng/dL
Glina et al., 202415 prospective studiesMean reduction 9.11 ng/dL
Glina et al., 20246 cross-sectional studiesMean reduction 55.02 ng/dL, high variability
Cochrane, 20216 randomized trials, atorvastatinNo significant difference (−0.20 nmol/L)
Schooling et al., 2013Randomized trials, 501 menAbout 3.4% lower

Does the statin, the dose or the duration matter?

This is where the data are thinnest, and honesty about that serves you better than a confident answer.

Two trials comparing simvastatin 80 mg per day with 40 mg per day, in 640 men, found median testosterone reductions of 10.3% and 7.5% after 48 weeks, which suggests a possible dose response. The same review said there were too few trials to assess dose effects or compare statin types firmly.

Observational data add texture without settling it. A 2008 study of men with type 2 diabetes in the United Kingdom found lower total testosterone in statin users (11.9 versus 13.4 nmol/L), but bioavailable and free testosterone and hypogonadal symptoms were not affected. The lowest total level was among men on at least 20 mg of atorvastatin, while simvastatin showed no significant reduction. Its design could not prove causation.

A 2000 placebo-controlled study of 81 men gave simvastatin 80 mg daily for 12 weeks. Total testosterone fell 13.6% versus 1.5% on placebo, but the between-group difference was not statistically significant (P=.09). Bioavailable testosterone fell 10.2% against a 1.4% rise on placebo (P=.035), while free testosterone and gonadotropins did not change significantly between groups.

And the Rotterdam Study in the Netherlands reported that current statin use was associated with lower total testosterone by about 1.1 to 1.2 nmol/L compared with non-use, again in an observational design.

The pattern: small differences in total testosterone, inconsistent signals in the fractions that act on tissue, and no trial that links the numbers to how men function.

Does the statin, the dose or the duration matter?

Total testosterone is not the whole picture

Most of the circulating total figure is bound to proteins, chiefly SHBG. Only a fraction is free or loosely bound and available to tissues. That is why a modest fall in the total number, with no significant change in free testosterone, SHBG or LH, as the 2024 review reported, is a weak basis for concluding that a man's hormonal function has changed.

If you want to go further into how these fractions work, our guides to free testosterone and to age-by-age testosterone ranges explain what each marker measures and why ranges are wide. Sensitivity at the receptor is a further layer, covered in our article on androgen receptor sensitivity and SHBG.

What Swedish guidance says about testing

If you live in Sweden, the clinical framework is clear and conservative. Janusinfo, the expert-group service from Swedish regions, advises against routine testosterone testing, and against screening middle-aged or older men with questionnaires or blood tests alone when there is no clinical suspicion of hypogonadism. Where testing is justified, it should be fasting and in the morning, a low result should be checked again, and the conclusion should rest on both symptoms and low levels.

A regional guideline from Västra Götaland, valid through April 2026, is more specific. It defines male hypogonadism as symptoms together with low plasma testosterone, recommends sampling fasting between 07:00 and 11:00, requires at least two low results for a diagnosis, and advises that a value below 12 nmol/L be repeated with LH and SHBG. Check with your own region for its current version.

The practical translation for a busy executive:

  1. Book the draw early. A mid-afternoon sample after a heavy lunch and a long day is not comparable with a fasting morning sample.
  2. Do not act on one number. A single low reading is a prompt to repeat, not a conclusion.
  3. Ask for the context markers. LH and SHBG help your physician interpret total testosterone.
  4. Bring symptoms, not just values. Persistent drop in drive, energy or sexual function, with the timeline of when your statin started, is what a clinician can work with.

Our guide on how to choose a hormone lab for men 40 to 65 covers the practical side of arranging reliable testing.

If you take a statin: how to handle the decision

Statins are the first-choice therapy for lowering LDL cholesterol in Swedish guidance, and that has a reason: the cardiovascular case for them is established. Your cholesterol plan is a cardiovascular decision, and it should stay with the physician who prescribed it. Do not stop or adjust a statin on your own because of something you read, including this article.

If you do have symptoms you are worried about, the sensible sequence is this:

  • Document first. Note when symptoms began relative to starting the statin or changing its dose, and whether sleep, weight, alcohol, stress or other medications changed in the same window.
  • Raise it with your physician. Present it as a question about cause, with your dates.
  • Test properly. Use the fasting, morning, repeated approach above.
  • Let the physician decide about the statin. Läkemedelsboken, the Swedish drug handbook, notes that if standard doses are not tolerated, very low or intermittent dosing such as rosuvastatin 5 mg two to three times weekly may be tried. That is a medical decision, made with your doctor.

Liver and metabolic health also interact with hormones and with statin therapy, which is why our overview of liver health and hormones in men is a useful companion if you are reviewing your full panel.

Perspective

Men in demanding roles tend to treat their own biology like any other asset: measure it, understand the variance, act on signal rather than noise. On statins and testosterone, the signal is modest and the uncertainty is real. That is not a reason for alarm. It is a reason for method.

At Viridos we build around that method. Our positioning is small-batch Swedish production, disciplined evidence handling and decision records you can inspect, so that evidence, reasoning and uncertainty stay visible and your professional judgment stays in charge. The same standard applies to your own data. Know your cholesterol plan, know your morning hormone panel, keep dates, and decide with your physician.

Our formulation is a plant-derived oral spray built on proprietary extraction methods and designed to deliver phytoandrogen-related compounds, with sublingual delivery as our philosophy. It is made for men who want to sustain drive, clarity and consistency over decades, within a disciplined routine that includes the medical foundations first. For the wider picture, our readers start with phytoandrogen effects in men and testosterone alternatives for men 40+.

Joakim

For men building a performance routine

Viridos is a controlled-access membership: approved applicants receive regular shipments of our precision oral spray, produced in small batches in Sweden. There are two plans, Member at $99 per month and Professional at $299 per month, and you can see both on the pricing page. If you want to understand how the membership works before applying, the membership page sets it out.

Viridos

For further reading on vitality and performance longevity, the Performance Journal collects our editorial work.

FAQ

Do statins lower testosterone?

On average, slightly. The 2024 meta-analysis found small reductions in total testosterone in randomized and prospective studies, while Cochrane's atorvastatin review found no significant difference from placebo. Average levels did not fall below normal, and the certainty of the evidence is limited.

Can statins cause symptoms of low testosterone?

The research does not show it. The 2024 review could not assess clinical symptoms, and free testosterone showed no significant difference. If you have persistent symptoms, discuss them with your physician and arrange a fasting morning test, repeated if low.

Does the type or dose of statin matter?

Possibly, but the data are too limited to say. Two simvastatin trials hinted at a larger reduction at 80 mg than at 40 mg, and one observational study saw the lowest totals with atorvastatin at 20 mg or more. Reviews state there are too few trials to compare types firmly.

Should I stop my statin if I am worried about testosterone?

No, not on your own. Statins are the first-choice cholesterol therapy in Swedish guidance, and changes belong with your prescribing physician. Bring your symptom timeline and morning test results, and let the doctor weigh options such as a different dose or schedule.

Sources